Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan E Sparks

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Molecular Genetics and Metabolism|March 3, 2006
Inherited disorders of glycosylationSusan E Sparks
North Carolina Medical Journal|December 10, 2013
Update on newborn screeningSusan E Sparks
The Application of Clinical Genetics|June 19, 2013
Congenital protein hypoglycosylation diseasesSusan E Sparks
Clinics in Perinatology|June 5, 2015
Neonatal hypotoniaSusan E Sparks
Handbook of Clinical Neurology|April 19, 2011
Congenital muscular dystrophiesSusan E Sparks, Diana M Escolar
Chemical Research in Toxicology|March 19, 2003
Major intermediates in organophosphate synthesis (PCl3, POCl3, PSCl3, and their diethyl esters) are anticholinesterase agents directly or on activationYoffi Segall, Gary B Quistad, Susan E Sparks, et al.
American Journal of Medical Genetics. Part A|October 16, 2007
Trisomy 9 mosaicism and XX sex reversalBenjamin D Solomon, Clesson E Turner, Darren Klugman, et al.
Toxicology and Applied Pharmacology|March 9, 2002
Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implicationsGary B Quistad, Susan E Sparks, Yoffi Segall, et al.
Toxicology Letters|September 24, 2002
Cannabinoid CB1 receptor as a target for chlorpyrifos oxon and other organophosphorus pesticidesGary B Quistad, Daniel K Nomura, Susan E Sparks, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2003
Evidence that mouse brain neuropathy target esterase is a lysophospholipaseGary B Quistad, Carrolee Barlow, Christopher J Winrow, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Molecular Genetics and Metabolism|March 3, 2006
Inherited disorders of glycosylationSusan E Sparks
North Carolina Medical Journal|December 10, 2013
Update on newborn screeningSusan E Sparks
The Application of Clinical Genetics|June 19, 2013
Congenital protein hypoglycosylation diseasesSusan E Sparks
Clinics in Perinatology|June 5, 2015
Neonatal hypotoniaSusan E Sparks
Handbook of Clinical Neurology|April 19, 2011
Congenital muscular dystrophiesSusan E Sparks, Diana M Escolar
Chemical Research in Toxicology|March 19, 2003
Major intermediates in organophosphate synthesis (PCl3, POCl3, PSCl3, and their diethyl esters) are anticholinesterase agents directly or on activationYoffi Segall, Gary B Quistad, Susan E Sparks, et al.
American Journal of Medical Genetics. Part A|October 16, 2007
Trisomy 9 mosaicism and XX sex reversalBenjamin D Solomon, Clesson E Turner, Darren Klugman, et al.
Toxicology and Applied Pharmacology|March 9, 2002
Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implicationsGary B Quistad, Susan E Sparks, Yoffi Segall, et al.
Toxicology Letters|September 24, 2002
Cannabinoid CB1 receptor as a target for chlorpyrifos oxon and other organophosphorus pesticidesGary B Quistad, Daniel K Nomura, Susan E Sparks, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2003
Evidence that mouse brain neuropathy target esterase is a lysophospholipaseGary B Quistad, Carrolee Barlow, Christopher J Winrow, et al.
Pageof 3